Review
Published on 25 Apr 2025
Dual roles of methylglyoxal in cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1557162
- 1,242 views
Type at least 3 characters
1,936 articles
Review
Published on 25 Apr 2025
Recent advances in therapeutic use of transforming growth factor-beta inhibitors in cancer and fibrosis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1489701
- 1,799 views
Original Research
Published on 24 Apr 2025
Expression of SMURF family in pancreatic cancer and its effect on cell proliferation and migration
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1538335
- 968 views
Original Research
Published on 17 Apr 2025
Development and validation of a prognostic model for post-surgical overall survival in Asian colon cancer patients: a real-world population-based study
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1541561
- 1,095 views
Review
Published on 15 Apr 2025
The role and clinical significance of tumor-associated macrophages in the epithelial–mesenchymal transition of lung cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1571583
- 1,770 views
- 1 citation
Brief Research Report
Published on 15 Apr 2025
Identifying antisense oligonucleotides for targeted inhibition of insulin receptor isoform A
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1563985
- 1,502 views
Original Research
Published on 15 Apr 2025
Tumor-associated macrophages correlate with better outcome in SHH medulloblastoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1557313
- 1,241 views
Original Research
Published on 14 Apr 2025
Best evidence summary for preventing and preventing epidermal growth factor receptor inhibitors induced paronychia in cancer patients
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1555114
- 1,380 views
Case Report
Published on 14 Apr 2025
Unexpected outcomes of tislelizumab treatment in thoracic metastasis of malignant phyllodes tumors: a case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1535653
- 1,530 views
Original Research
Published on 11 Apr 2025
PITX1 as a grading, prognostic and tumor-infiltrating immune cells marker for chondrosarcoma: a public database-based immunoassay and tissue sample analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1477649
- 1,089 views
Original Research
Published on 10 Apr 2025
NETs-related genes predict prognosis and are correlated with the immune microenvironment in osteosarcoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1551074
- 1,099 views
- 1 citation
Original Research
Published on 08 Apr 2025
Lnc-CNNM3-DT as a protective factor in cervical cancer: regulation of LIAS expression and intracellular copper levels
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1571788
- 1,103 views
Original Research
Published on 08 Apr 2025
FGFR3-TACC3 fusion gene promotes glioblastoma malignant progression through the activation of STAT3 signaling pathway
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1560008
- 2,059 views
Review
Published on 08 Apr 2025
The biological role and molecular mechanism of transfer RNA-derived small RNAs in tumor metastasis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1560943
- 949 views
Case Report
Published on 07 Apr 2025
Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1527484
- 1,431 views
Review
Published on 07 Apr 2025
Intrathecal pemetrexed chemotherapy combined with systemic therapy in patients with non-small cell lung cancer and leptomeningeal metastases: a retrospective study
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1545174
- 1,607 views
- 1 citation